Triplex Selective 2-(2-Naphthyl)quinoline Compounds: Origins of Affinity and New Design Principles
摘要:
A novel competition dialysis assay was used to investigate the structural selectivity of a series of substituted 2-(2-naphthyl)quinoline compounds designed to target triplex DNA. The interaction of 14 compounds with 13 different nucleic acid sequences and structures was studied. A striking selectivity for the triplex structure poly dA:[poly dT](2) was found for the majority of compounds studied. Quantitative analysis of the competition dialysis binding data using newly developed metrics revealed that these compounds are among the most selective triplex-binding agents synthesized to date. A quantitative structure-affinity relationship (QSAR) was derived using triplex binding data for all 14 compounds used in these studies. The QSAR revealed that the primary favorable determinant of triplex binding free energy is the solvent accessible surface area. Triplex binding affinity is negatively correlated with compound electron affinity and the number of hydrogen bond donors. The QSAR provides guidelines for the design of improved triplex-binding agents.
ANTAGONISM OF IMMUNOSTIMULATORY CPG-OLIGONUCLEOTIDES BY 4-AMINOQUINOLINES AND OTHER WEAK BASES
申请人:UNIVERSITY OF IOWA RESEARCH FOUNDATION
公开号:EP1377554A1
公开(公告)日:2004-01-07
US6479504B1
申请人:——
公开号:US6479504B1
公开(公告)日:2002-11-12
[EN] ANTAGONISM OF IMMUNOSTIMULATORY CPG-OLIGONUCLEOTIDES BY 4-AMINOQUINOLINES AND OTHER WEAK BASES<br/>[FR] ANTAGONISME DES OLIGONUCLEOTIDES CPG IMMUNOSTIMULATEURS PAR DES 4-AMINOQUINOLINES ET AUTRES BASES FAIBLES
申请人:UNIV IOWA STATE RES FOUND
公开号:WO2000076982A1
公开(公告)日:2000-12-21
The present invention relates generally to the field of immunology. More particularly it concerns compositions and methods for inhibiting stimulation of the immune system. The compounds and methods comprise compounds that are analogs and derivatives of chloroquine, such as 4-aminoquinolines, and other weak bases. They can be used in preventative and therapeutic treatments of autoimmune diseases and phenomena, transplant rejection such as host-versus-graft disease, and sepsis.
Triplex Selective 2-(2-Naphthyl)quinoline Compounds: Origins of Affinity and New Design Principles
作者:Jonathan B. Chaires、Jinsong Ren、Maged Henary、Oliwia Zegrocka、G. Reid Bishop、Lucjan Strekowski
DOI:10.1021/ja034181r
日期:2003.6.1
A novel competition dialysis assay was used to investigate the structural selectivity of a series of substituted 2-(2-naphthyl)quinoline compounds designed to target triplex DNA. The interaction of 14 compounds with 13 different nucleic acid sequences and structures was studied. A striking selectivity for the triplex structure poly dA:[poly dT](2) was found for the majority of compounds studied. Quantitative analysis of the competition dialysis binding data using newly developed metrics revealed that these compounds are among the most selective triplex-binding agents synthesized to date. A quantitative structure-affinity relationship (QSAR) was derived using triplex binding data for all 14 compounds used in these studies. The QSAR revealed that the primary favorable determinant of triplex binding free energy is the solvent accessible surface area. Triplex binding affinity is negatively correlated with compound electron affinity and the number of hydrogen bond donors. The QSAR provides guidelines for the design of improved triplex-binding agents.
Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
申请人:The University of Iowa Research Foundation
公开号:US06479504B1
公开(公告)日:2002-11-12
The present invention relates generally to the field of immunology. More particularly it concerns compositions and methods for inhibiting stimulation of the immune system. The compounds and methods comprise compounds that are analogs and derivatives of chloroquine, such as 4-aminoquinolines, and other weak bases. They can be used in preventative and therapeutic treatments of autoimmune diseases and phenomena, transplant rejection such as host-versus-graft disease, and sepsis.